Although Bayer’s top-selling drug Xarelto lost market exclusivity in most geographies in 2024, the company still predicts it will see strong growth from the pharma business unit beginning in 2027.
Growth is on the horizon for German drug conglomerate Bayer (BAYRY), despite “falling sales of its blockbuster blood thinner Xarelto,”amid ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
“We played them in that first game before, and we came out on fire. It is extra motivation for us. We are at home, we are a strong team at home, and it’s extra special when we play them.” ...
Since becoming Bayer's CEO, Bill Anderson has introduced striking changes to the company, including an overhaul of its budget system, which he sees as the driving source of corporate bureaucracy.
Bill Anderson has shaken up Bayer employees’ day-to-day since taking charge in 2023. © 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site ...
Faced with huge debt, the impending expiry of a crucial patent, and ongoing litigation over a horror acquisition, Bayer CEO Bill Anderson made a bold move a year ago to get his damaged company ...
Schick has scored nine goals in his last five Bundesliga matches Patrik Schick scored four goals to help Bayer Leverkusen thrash Freiburg 5-1 and narrow the gap with leaders Bayern Munich at the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback